CVS Pharmacy to pay $1.5M for violations of the Controlled Substances Act

CVS PHARMACY has agreed to pay $1.5 million for violations of the Controlled Substances Act in New York to resolve a federal investigation. Stores on Long Island had failed to report loss or stolen controlled substances in a timely manner. / BLOOMBERG FILE PHOTO/CHRISTOPHER LEE
CVS PHARMACY has agreed to pay $1.5 million for violations of the Controlled Substances Act in New York to resolve a federal investigation. Stores on Long Island had failed to report lost or stolen controlled substances in a timely manner. / BLOOMBERG FILE PHOTO/CHRISTOPHER LEE
WOONSOCKET – CVS Pharmacy Inc., the subsidiary of CVS Health Corp., has agreed to pay $1.5 million to resolve a federal investigation into certain stores on Long Island, N.Y., that failed to report the loss or theft of controlled substances, including the opioid hydrocodone, the U.S. Department of Justice announced Thursday. “The failure to promptly…

Want More Free?

To access 2 more articles, please log in or register for free.

Registered users get access to a limited number of free articles every month.

Register Now

Already registered? Login to access more free articles.

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -